Temenos AG (OTCMKTS:TMNSF - Get Free Report) rose 3.7% during mid-day trading on Tuesday . The company traded as high as $78.44 and last traded at $78.44. Approximately 800 shares were traded during trading, an increase of 471% from the average daily volume of 140 shares. The stock had previously closed at $75.63.
Temenos Stock Performance
The business's fifty day moving average price is $75.43 and its 200-day moving average price is $77.36.
Temenos Company Profile
(
Get Free Report)
Temenos AG develops, markets, and sells integrated banking software systems to banking and other financial institutions worldwide. Its Temenos Banking Cloud helps banks to offer open banking services. The company provides Temenos Infinity, a digital banking platform; Temenos Transact, a core banking software for retail, corporate, treasury, wealth, and payments; Temenos Payments, a software-as-a-service payments technology; Temenos Multifonds, a platform for traditional and alternative funds, as well as offers key asset servicing, position keeping, valuation and accounting functions for various structures of pooled vehicles and funds; Temenos Multifonds Navigator, a net asset value shadow, oversight, and contingency solution; and Temenos Quantum, a multi-experience development platform.
See Also
Before you consider Temenos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Temenos wasn't on the list.
While Temenos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.